Lentiviral Vectors Having a Mutated Integrase Protein and uses Thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160230190A1
SERIAL NO

15022722

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a lentiviral vector wherein the expressed integrase protein comprises at least one point mutation consisting of the substitution of the aspartic acid residue at position 167 by an amino acid selected from the group consisting of histidine, arginine and lysine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013
CEA25 RUE LEBLANC BATIMENT LE PONANT D PARIS 75015
UNIVERSITE PARIS SUD15 RUE GEORGES CLEMENCEAU ORSAY 91405

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dufour, Noelle Le Kremlin Bicetre, FR 3 13
Lachapelle, Francois Le Kremlin Bicetre, FR 1 1
Saeed, Muhammad Qamar Le Kremlin Bicetre, LE 1 1
Serguera, Che Le Kremlin Bicetre, FR 4 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation